Yüklüyor......
Synergistic effect of ibrutinib and CD19 CAR‐T cells on Raji cells in vivo and in vitro
Ibrutinib might improve the efficacy of anti‐CD19 chimeric antigen receptor (CD19 CAR) T‐cell therapy in chronic lymphocytic leukemia (CLL). We studied the possibility and mechanism of the synergistic effect of ibrutinib and CAR‐T cells in other types of lymphoma. In this study, we selected the CD19...
Kaydedildi:
| Yayımlandı: | Cancer Sci |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7648031/ https://ncbi.nlm.nih.gov/pubmed/32876369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14638 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|